Castle Biosciences, Inc. (CSTL) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Castle Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.659 to Castle Bioscience's third quarter 2025 results conference call. 00:00:04.659 -- 00:00:09.088 Joining me today are Castle's founder, president, and chief executive officer, Derrick 00:00:09.088 -- 00:00:14.137 Matfield, chief financial officer, Frank Stokes, and senior vice president medical, 00:00:14.137 -- 00:00:19.386 Dr. Matthew Goldberg, board certified dermatologist and dermatopathologist. 00:00:19.386 -- 00:00:24.500 Information recorded on this call speaks only as of today, November 3rd, 2025. 00:00:24.500 -- 00:00:28.347 Therefore, if you are listening to the replay or reading the transcript of this call, 00:00:28.347 -- 00:00:31.813 any time-sensitive information may no longer be accurate. 00:00:31.813 -- 00:00:36.160 A recording of today's call will be available on the investor relations page of the company's 00:00:36.160 -- 00:00:40.688 website for approximately three weeks following the conclusion of the call. 00:00:40.688 -- 00:00:44.495 Before we begin, I would like to remind you that some of the statements made today will 00:00:44.495 -- 00:00:49.711 contain forward-looking statements, including statements about expected addressable markets 00:00:49.711 -- 00:00:54.798 Statements containing projections regarding future events or our future financial or 00:00:54.798 -- 00:00:59.865 operational results and performance, including our anticipated 2025 total 00:00:59.865 -- 00:01:04.992 revenue and the impact of our investment and growth initiatives, including our ability 00:01:04.992 -- 00:01:09.478 to achieve long-term growth and drive stockholder value. 00:01:09.478 -- 00:01:14.124 Forward-looking statements are based upon current expectations and involve inherent risks 00:01:14.124 -- 00:01:18.579 and uncertainties...